EFTA00304964.pdf

EARt[ Pc 09 1 LabCoro Raritan Laouorp 69 First Avenue Raritan, NJ 08869-1800 ('hone: 877-547-6837 N, „,...„ Nth ,R., 263-480-2797-0 l'..n: II) II Connol NomIni CNT31143092 Acoand No 31143092 ”I —nnsni Minn< Nun d,r , 212-535-1012 Ho w 70 EPSTEIN mw ifi lddN m , A,,,. n. ..IA.w., Woodson Merrell 44 E 67th St New York NY 10065 I'.“ , r I \,n, JEFFREY l'ancout Allan.: bialvol.m. An- 01101), 60/08/00 ItncAndth 01/20/53 'w ii M laginr. I'dficni Atkin:, 9 E 71ST ST NEW YORK NY 10065 Additional Innitnunon UPIN: A62553 hate and I MC (OIICO•Ai 09/20/13 14:00 hale I 111{10 09/21/13 I /AO 31111 I my '<ginned 09/25/13 15:06ET Pli).n.i.d. %auk. MERRELI. , W Nil 1023153509 Ps),Kisilp MERRELL I co. /Meted NMR LipoProfile; CBC With Differential/Platelet; Comp. Metabolic Panel 114): PE.Interp(Rfx IFE).5; Lyme Ab/Western Blot Reflex Iron and TIBC; Testosterone,Pree+weakly Bound; Prolactin; OHM-Sulfate; Homocystle)ine. Plasma; C-Reactive Protein, Cardiac: Hemoglobin Ale: Prostate-Specific Ag. Serum TSH; Vitamin D, 25-Hydroxy; Uric Acid, Serum; GOT; Insulin; Ambiguous Test Order; Ferritin, Serum Request Problem TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB NMR LipoProfile LDL Particle Number LDL-P Lipids LDL-C LDL-C cannot be HDL-C Triglycerides Cholesterol, Total LDL and HDL Particles HDL-P (Total) Small LDL-P LDL Size 2111 High nmol/L Low Moderate Borderline-High High Very High <1000 < 1000 1000 - 1299 1300 - 1599 1600 - 2000 NOTES: mg/dL calculated because triglycerides are > 400 28.7 1548 19.8 Low High High Low High Low Optimal Above optimal Borderline High Very high mg/dL mg/dL mg/dL umo3/L nmol/L DM > 2000 <100 mg/dL. 100 130 160 *** INTERPRETATIVE INFORMATION*** PARTICLE CONCENTRATION AND SIZE <--Lower CVD Risk Higher CVD Risk--> LDL AND HDL PARTICLES Percentile in Reference Population HDL-P (total) High 75th 50th 25th Low >34.9 . 34.9 30.5 26.7 <26.7 >=40 <150 <200 100 129 159 189 189 >= 30.5 <= 527 > 20.5 01 01 01 01 01 01 01 01 01 01 01 EPSTEIN, JEFFREY 263-480-2797-0 Seq 6 5515 09/25/13 15:06 ET FINAL REPORT This document contains plivaie and confidential health informal icn protected by state and federal law. If you have received this document in error. please call 800-631-5250 Page 1 of 6 02004-o Laboratory Corporation of America Holdings All Rights Reserved DOC I Va. 1.49 EFTA00304964 LakCeop {IAMBI Naar EPSTEIN, JEFFREY Specimen Mundy. 263-480-2797-0 .v. dtaa Smith,' 31143092 I to oto ID Control Mitotic' CNT31143092 Date and Time Collected 09/20/13 14:00 Date Remittal 09/25/13 SD. M AttelY/WDI 60/08/00 Date of Bull 01/20/53 LabCorp Raritan 69 First Avenue Raritan. NJ 08869-1800 Phone. 877-547-6837 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Small LDL-P Low 25th 50th 75th High <117 117 527 839 >839 LDL Size <-Large (Pattern A)-> <-Small (Pattern B)-> 23.0 20.6 20.5 19.0 Insulin Resistance Score LP-IR Score 100 High LP-IR Score is inaccurate if patient is non-fasting. The LP-IR Score combines information from lipoprotein particle concentration and size to give improved assessment of insulin resistance and diabetes risk. Small LDL-P, LDL Particle Size, HDL-Particle, and LP-IR Score have been validated by LipoScience but not cleared by US FDA; the clinical utility of these test results has not been fully established. INSULIN RESISTANCE MARKER <--Insulin Sensitive Insulin Resistant--> Percentile in Reference Population Insulin Resistance Score LP-IR Score Low 25th 50th 75th High <27 27 45 63 >63 CBC With Differential/Platelet WBC 6.4 x10E3/uL 3.4 10.8 02 RBC 5.24 x10E6/uL 4.14 5.80 02 Hemoglobin 15.3 g/dL 12.6 17.7 02 Hematocrit 43.9 37.5 51.0 02 MCV 84 fL 79 97 02 MCH 29.2 pg 26.6 33.0 02 MCHC 34.9 g/dL 31.5 35.7 02 RDW 14.3 12.3 15.4 02 Platelets 269 xl0E3/uL 155 379 02 Neutrophils 56 40 74 02 Lymphs 31 14 46 02 Monocytes 8 4 12 02 Eos 4 0 5 02 Basos 1 0 3 02 Neutrophils (Absolute) 3.6 xl0E3/uL 1.4 7.0 02 Lymphs (Absolute) 2.0 x10E3/uL 0.7 3.1 02 Monocytes(Absolute) 0.5 xl0E3/uL 0.1 0.9 02 Eos (Absolute) 0.3 xl0E3/uL 0.0 0.4 02 Baso (Absolute) 0.1 xl0E3/uL 0.0 0.2 02 Immature Granulocytes 0 0 2 02 Immature Grans (Abs) 0.0 xl0E3/uL 0.0 0.1 02 01 <= 45 01 EPSTEIN, JEFFREY 263-480-2797-0 Seq 65515 09/25/13 15:06 FT FINAL REPORT This document contains private and contidential health information protected by state and federal law. If you have received dm document in mut. please call 800-631-5250 Page 2 of 6 01004-13 Laboratory Corporation of Ante( Ica m Holdings All Righu Reserved DOCI Ver. 1.49 EFTA00304965 Loci3Com EPSTEIN, JEFFREY 263-480-2797-0 31143092 t‘incell) C.oll.4N.Oet CNT31143092 I /.5Ie aml I inn' “dir. icd 09/20/13 14:00 Rile ileilitled 09/25/13 Sc • M A.,.1 'NCI ) 60/08/00 l,,,,I lluth 01/20/53 TESTS RESULT FLAG Comp. Metabolic Panel (14) Glucose, Serum (1103 High) BUN 19 Creatinine, Serum 0.94 eGFR if NonAfricn Am 88 eGFR If Africn Am 101 BUN/Creatinine Ratio 20 Sodium, Serum 139 Potassium, Serum 4.1 Chloride, Serum 98 Carbon Dioxide, Total 19 Calcium, Serum 10.1 Protein, Total, Serum 7.3 Albumin, Serum 4.5 Globulin, Total 2.8 A/G Ratio 1.6 Bilirubin, Total 0.6 Alkaline Phosphatase, S 58 LabCorp Raritan 69 First Avenue Raritan. NJ 08869-1800 Mow 877-547-6837 AST (SCOT) ALT (SGPT) PE+Interp(Rfx IFE),S Albumin Alpha-1-Globulin Alpha-2-Globulin Beta Globulin Gamma Globulin M-Spike Globulin, Total A/G Ratio Please note: Protein electrophoresis courier delivery. Interpretation(See Below) The SPE pattern appears essentially monoclonal protein is not apparent. High 4.2 0.2 0.8 1.0 1.0 Not Observed 3.1 1.4 UNITS REFERENCE INTERVAL LAB mg/dL mg/dL mg/dL mL/min/1.73 mL/min/1.73 mmol/L mmol/L mmol/L mmol/L mg/dL g/dL g/dL g/dL mg/dL IU/L IU/L IU/L g/dL g/dL g/dL g/dL g/dL g/dL g/dL 65 8 0.76 10 134 3.5 97 19 8.6 6.0 3.6 1.5 1.1 0.0 44 0 0 - 99 - 27 - 1.27 >59 >59 - 22 - 144 - 5.2 - 108 - 28 - 10.2 - 8.5 - 4.8 - 4.5 - 2.5 - 1.2 - 102 - 40 - 44 3.2 - 0.1 - 0.4 - 0.6 - 0.5 - 5.6 0.4 1.2 1.3 1.6 Not Observed 2.0 - 4.5 0.7 - 2.0 scan will follow via computer, mail, or unremarkable. Evidence of Lyme Ab/Western Blot Reflex Lyme IgG/IgM Ab 0.92 High index 0.00 - 0.90 Negative <0.91 Equivocal 0.91 - 1.09 Positive >1.09 Note: The CDC currently advises that Western blot testing be performed following all equivocal or positive EIA results. Final diagnosis should include appropriate clinical findings and a positive EIA which is also positive by Western blot. 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 EPSTEIN, JEFFREY 263-480-2797-0 Seq M 5515 09/25/13 15:06 ET FINAL REPORT This document contains private and confidential health information protected by state and federal law. If you have received this document in crux. please call 800-631-5250 Page 3 of 6 02004-13 Laboratory Corporation of America Holdings All Rights Reserved DOCI Ver. 1.49 EFTA00304966 La kaggrp Patient Name EPSTEIN, JEFFREY Specimen N, i h'. , 263-480-2797-0 %."..w...6. 31143092 Pawn. In CONS Mantel CNT31143092 Dale and Tiny Collected 09/20/13 14:00 Daw Reported 09/25/13 Se% M ApeiSAI/Di 60/08/00 13,Oc , , —Hi. 01/20/53 LabCorp Raritan 69 First Avenue Raritan, NJ 08869-1800 Phone- 877-547-6817 TESTS RESULT FLAG UNITS RISTERENCE INTERVAL LAD Lyme Ab Interp.,E1A Lyme Ab IgG by WB: IgG P93 Ab. IgG P66 Ab. IgG P58 Ab. IgG P45 Ab. IgG P41 Ab. IgG P39 Ab. IgG P30 Ab. IgG P28 Ab. IgG P23 Ab. IgG P18 Ab. Lyme IgG WB Interp. Positive: 5 of the following Borrelia-specific bands: 18,23,28,30,39,41,45,58, 66, and 93. Negative: No bands or banding patterns which do not meet positive criteria. Lyme Ab IgM by WB: 02 IgM P41 Ab. Absent 02 IgM P39 Ab. Absent 02 IgM P23 Ab. Absent 02 Lyme IgM WE Interp. Negative 02 Note: An equivocal or positive EIA result followed by a negative Western Blot result is considered NEGATIVE. An equivocal or positive EIA result followed by a positive Western Blot is considered POSITIVE by the CDC. Equivocal Absent Absent Present Abnormal Absent Present Abnormal Absent Absent Absent Absent Absent Negative 0 02 02 02 02 02 02 02 02 02 02 02 02 02 Positive: 2 of the following bands: 23,39 or 41 Negative: No bands or banding patterns which do not meet positive criteria. Criteria for positivity are those recommended by CDC/ASTPHLD. p23=Osp C, p41=flagellin Note: Sera from individuals with the following may cross react in the Lyme Western Blot assays: other spirochetal diseases (periodontal disease, leptospirosis, relapsing fever, yaws, and pinta); connective autoimmune (Rheumatoid Arthritis and Systemic Lupus Erythematosus and also individuals with Antinuclear Antibody); other infections (Rocky Mountain Spotted Fever; Epstein-Barr Virus, and Cytomegalovirus). Lyme Disease Ab, Quant, IgM <0.91 index 0.00 - 0.90 02 Negative <0.91 EPSTEIN, JEFFREY 263-480-2797-0 Seri a 5515 09/25/13 15:06 ET FINAL REPORT This document contains private and confidential health infonnaliOn protected by state and federal law. If you have received this document in time, please call 800-631-5250 Page 4 of 6 O2004-B Laboratory Corpoi anon of America la Holdings All Rights Reserved DOCI Vet. 1.49 EFTA00304967 LabCorp NwmNmw SpodinoNwOn EPSTEIN, JEFFREY 263-480-2711t0 s... .mswo.1 31143092 PaOm II) Conuol Nunftf CNT31143092 flue and 09/20/13 14:00 Mm Reuened 09/25/13 Sex M AROYAM 60/08/00 4.01Mb 0/53 LabCorp Raritan 69 First Avenue Raritan, NJ 08869-1800 Phone. 877-547-4837 TESTS RESULT !LILO lawn. RIMSIUDICE XliTZRVAL LAS Equivocal 0.91 - 1.09 Positive >1.09 Note: IgM levels may peak at 3-6 weeks post infection, then gradually decline. FDA currently advises that Western Blot testing be performed following all equivocal or positive EIA results. Final diagnosis should include appropriate clinical findings and a positive EIA which is also positive by Western Blot. Iron and TIBC Iron Bind.Cap.(TIBC) UIBC Iron, Serum Iron Saturation Testosterone,Free+weakly Bound Testosterone, Serum Prolactin DHEA -Sulfate Homocyst(e)ine, Plasma C-Reactive Protein, Cardiac Hemoglobin Alc 329 ug/dL 250 - 450 244 ug/dL 150 - 375 85 ug/dL 40 - 155 26 % 15 - 55 178 Low ng/dL 348 - 1197 4.2 ng/mL 4.0 - 15.2 02 02 02 02 207.7 ug/dL 51.7 - 295.0 02 **Please note reference interval change** 12.8 umol/L 0.0 - 15.0 02 1.04 mg/L 0.00 - 3.00 02 Relative Risk for Future Cardiovascular Event Low <1.00 Average 1.00 - 3.00 High >3.00 High Increased risk for diabetes: 5.7 - 6.4 Diabetes: >6.4 Glycemic control for adults with diabetes: <7.0 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum Roche ECLIA methodology. 0.8 ng/mL 4.8 - 5.6 02 0.0 - 4.0 02 According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory PSA value 0.2 ng/mL or greater. EPSTEIN, JEFFREY 263-480-2797-0 Seq./5515 09/25/13 15:06 ET FINAL REPORT Ibis document contains cm, ale and confidential health information protected by slate and federal law. If you have recerdcd this document in cnor. please call 800-631-5250 Page 5 of 6 02004-13 Laboratory Corporation of America ® Holdings All Rights Reserved DOCI Ver. 1.49 EFTA00304968 LabCorp Raritan 69 First Avenue Raritan. NJ 08869-1800 Phone. 877-C47-6817 NimemNanse EPSTEIN, JEFFREY 263-480-2797-0 31143092 ii, ('M 0 Mmther CNT31143092 Mlle mild Time CWInied 09/20/13 14:00 Dar Itelloned 09/25/13 Se + M AO YAM M 60/08/00 IX* orMell 01/20/53 TESTS RESULT nate SNITS REFERENCE INTERVAL LAB Values obtained with different assay methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. TSH 1.680 u/U/mL 0.450 - 4.500 02 vitamin D, 25-Hydroxy 41.4 ng/mL vitamin D deficiency has been defined by the Institute of 30.0 - 100.0 02 Medicine and an Endocrine Society practice guideline as a level of serum 25-0H vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/mL (2). 1. ION (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press. 2. Bolick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. JCEM. 2011 Jul; 96(7):1911-30. Uric Acid, Serum Uric Acid, Serum 7.1 mg/dL 3.7 - 8.6 Please Note: Therapeutic target for gout patients: <6.0 GGT 18 Insulin IU/L 0 - 65 High uIU/mL 2.6 - 24.9 Ambiguous Test Order Attempts to contact your facility to clarify an ambiguous test order were unsuccessful. Please contact the laboratory to verify the request. Specimens are (7 outinely held for 7 days from date of receipt. Ambiguous test order: A 028240 Ferritin, Serum :910: ele i b itiC10 ) 121 ng/mL 30 - 400 Request Problem Test Not Performed. Specimen is lipemic. TEST: 143257 Testost., % Free+Weakly Bound Panel: 143255 02 02 02 02 02 02 03 01 S7 LipoScience Inc Dir: Deanna Franke, PhD 2500 Sumner Blvd. Raleigh. NC 27616-3235 02 RN LabCorp Raritan Dir: Aracell B Reyes, MD 69 Pirst Avenue, Raritan. NJ 08869-1800 03 BN LabCorp Burlington Dir: William F Hancock. MD 1447 York Court, Burlington, NC 27215-3361 For inquiries, the physician may contact Branch: 800-631-5250 Lab: 877-547-6837 EPSTEIN, JEFFREY 263-480-2797-0 Seq./ 5515 09/25/13 15:06 ET FINAL REPORT This document contains private and confidential health information protected by slate and federal law If you have received this document in mot. please call 800-631-5250 Page 6 of 6 O2004. l) Laboratory Corporation of America Holdings All Rights Reserved DOCI Ver 1.49 EFTA00304969 Laboratory Corporation of America Special Chemistry Department Raritan, New Jersey Serum Protein Electrophoresis Specimen Number 263480279706 Account No./Name: 31143092-Woodson Merrell Total Protein: 7.3 DID: Patient Name: EPSTEIN,JEFFREY Account Address 1: Patient Id: Account Address 2: 44 E 67th St Birthdate: 20-JAN-1953 Account Address 3: New York, NY 10065 SPIFE SPE Split Beta Sample 9 09-23-2013 12:45:08:08 Status: 0k Fraction 96 gidis g/dL Range Albumin 58.1 4.2 3.2 5.6 Alpha 1 2.7 0.2 0.1 0.4 Alpha 2 11.2 0.8 0.4 1.2 Beta 13.9 1.0 0.6 1.3 Gamma 14.1 1.0 0.5 1.6 Total 7.3 6.0 8.5 Comment The SPE pattern appears essentially unremarkable. Evidence of monoclonal protein is not apparent. EFTA00304970 LabCorp 263-480-2797-1 Paiigen) °maul Hung= CNT31143092 Ammo' Number 31143092 Meagan Phone Number 212-535-1012 Row 70 NimmIsmNalm EPSTEIN MommAddism Woodson Merrell 44 E 67th St New York NY 10065 I . JEFFREY par.cusikuvsmw roealsol.... Ag itemMh Imes Birth Sex 60/08/00 01/20/53 M Uaami, Patine MKS. 9 E 71ST ST NEW YORK NY 10065 AddahxrunOnm‘m.m UPIN: A62553 Dale and Time Collected I 09/20/13 14:00 Da Ern; I 09/25/13 Dete and nay Nrwird 09/26/13 09:05ET MI) u. i.m Nam- MERRELL , W NM 1023153509 mi'mcon ID MERRELL LabCorp Raritan 69 First Avenue Raritan. NJ 08869-1800 Phone: — Is Ordered FSH and LH: Written Authorization TESTS RESULT TYLAO UNITS REFERENCE INTERVAL ran Fell and LH LH FSH 5.3 4.5 Written Authorization Written Authorization Received. Authorization received from SIGNATURE FILE Logged by Anca Orban mIU/mL mIU/mL 09-25-2013 1.7 - 8.6 01 1.5 - 12.4 01 01 01 RN LabCorp Raritan Dir: Araceli B Reyes, ND 69 First Avenue, Raritan, NJ 08869-1800 For inquiries, the physician may contact Branch: 800-631-5250 Lab: 800-631-5250 EPSTEIN, JEFFREY 263-480-2797-1 Seq 0 5522 09/26/13 09:06 ET FINAL REPORT This document contains private and confidential health information protected by state and federal law. If you have received this document in error. please call 8 0 0 -631-5250 Page 1 of 1 WON-II Laboratory Coiporation of America 0 Holdings All Rights Reserved DOCI Ver I.34 EFTA00304971 LabCorp K 263-480-3235-0 NOW'. 111 Comol Nutawr CMK31143092 Access Numtwr 31143092 Account) Maw Numbs 212-535-1012 Nwic 70 'siege I JA NJIAC EPSTEIN /woman) Adds.. Woodson Merrell 44 E 67th St New York NY 10065 I•i p., I...I +.:r JEFFREY Noes Nikklk Name hul V alium % I :low 60/08/00 01/20/53 M aiss &Strew 9 EAST 71ST ST NEW YORK NY 10065 AiMmogul W." mw. w UPIN: A62553 Hue awn me fit owl 09/20/13 14:00 I Wm I meted I 09/21/13 floe and Timc )(twee.) 09/26/13 09:0SET Mywcom) Nw w MERRELL , W NM 1023153509 I lo went') M LabCorp Raritan 69 First Avenue Raritan. N 08869-1800 Phone. 800-762-4344 Tor) I ktlered Lp-PLA2 TESTS RESULT FLEE UNITS RErens:ea INTERVAL LAS Lp-PLA2 137 ng/mL Low Risk Moderate High Risk Risk 131 200 - 199 <200 - 235 >235 01 01 BE LabCorp Burlington Dir: William F Hancock. MD 1447 York Court, Burlington, NC 27215-3361 For inquiries, the physician may contact Brancht 800-631-5250 Labs 800-762-4364 EPSTEIN, JEFFREY 263-480-3235-0 Seq 05523 09/26/13 09:06 ET FINAL REPORT This document contains private and confidential health information protected by slate and federal law If you have received this document in error, please call 800-631-5250 Page 1 of 1 O2004-13 Laboratory Corporation of America e Holdings All Rights Reserved D0CI Ver. I49 EFTA00304972 4OCprp LabCorp Raritan 69 First Avenue Raritan, NJ 08869-1800 Phone: 800-444-9111 siwirticoNund,a 263-4 8 0-3234-0 NewillW CcatelNmftr CMJ31143092 AccouNNumbn 31143092 AmmaiMumNumilt 212-535-1012 Roma 70 RoinglamNartic EPSTEIN AccmmASWsN Woodson Merrell 4 4 E 67th S t New York NY 10065 PamwhimNow PaticsMidtkNana laalVolurm Ay( h Sex l'aqing 60/08/00 01/20/53 M PaiiamAddmk• 9 EAST 71ST NEW YORK NY 10021 AdlotonallMmatalion UPIN: A62553 micammenceorkow 09/20/13 00:00 Datermeted 09/21/13 IrldeaSTimelrepimed 09/25/13 09 :05ET MlywunNarme MERRELL, , W NM 1023153509 PhyuctudD lems(k.WW Dihydrotestosterone TESTS UNITS REFERENCE INTERVAL LAB Iiihydrotestosterone Oihydrotestomterone Reference Range: Adult Male: 30 - 85 ng/dL 01 01 ES Esoterix Endocrinology Dir: Samuel Pepkowitz, MD 4301 Lost Hills Road, Calabasas Hills, CA 91301-5358 For inquiries, the physician may contact Branch, 800-631-5250 Labs 800-444-9111 EPSTEIN, JEFFREY 263-480-3234-0 Seritt5509 09/25/13 09:05 ET FINAL REPORT This document contains private and confidential health infomution mteecred by slate and federal law. If you have received this document in error. pkase call 800-631-5250 Page 1 of 1 01004-Il Laboratory Corporation of America <9 Holdings All Rights Reserved DOC I Ver 1.49 EFTA00304973 LabCorp Raritan 69 First Avenue Wx.rolandetwyermonoirgam7,441.— Raritan. NJ 08869-1800 Phone: 800-631-5250 %rt, in, ri ',him'', 1 263-042-7600-0 Nieto( ID ( ol4 Nootbei CML31143092 Awniimi Nuinbee 31143092 ,%,. mail Phonc Nunther 212-535-1012 {044C 70 ..i6,401.”.1 .4All•C EPSTEIN A...4nm, Ail. In Woodson Merrell 44 E 67th St New York NY 10065 raficiii I am \ame JEFFREY raliCiol Atallk N titic loul Vol...h. Are I YAVDI 60/08/00 I >ale of limb Sc. I.Runr 01/20/53 M No Nicol \ddrrn ALkklioaal Ildolnialitili Dale MO flint Collected 09/20/13 14:00 I Ilk I tec,' 09/21/13 pale aid lime Iterocicd 09/21/13 15:05ET Phy.kun Name Nil My. ian II) MERRELL fl.m.ronkred Fibrinogen Rct'vity TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Fibrinogen Activity 355 mg/dL 193 - 507 Specimen was ultracentrifuged before testing to remove extreme lipemia. Results should be interpreted with caution. 01 01 RN LaioCerp Raritan Dir: Araceli B Reyes, MD 69 First Avenue. Raritan, NJ 08869-1800 For inquiries, the physician may contact Branch, 800-631-5250 Lab: 800-631-5250 EPSTEIN, JEFFREY 263-042-7600-0 I Seqa5484 09/21/13 15:06 ET FINAL REPORT Dus document contains pnvate and confidential health information protected by stale and federal law. If you have received this document in crux. please call 800-631-5250 Page 1 of 1 02004-13 Laboratory Corporation of America 0 Holdings All Rights Reserved DOCI Ver: 1.49 EFTA00304974 LabCopRarimn !#!..Cc o.FP Raritan. NJ 08869-1800 69 First Avenue S” , , . N, . , 263-480-2784-0 Pm icor III Como* tanty CMS31143092 etc. tan Mimetic. 31143092 Munroe Phew No mbre 212-535-1012 Re weer 70 kmicffluimm...c EPSTEIN Accomindtw.... Woodson Merrell 44 E 67th St New York NY 10065 raticree I HO NMI*: JEFFREY Pamir Middle Name rouvol. Ate IY/NVD o I 60/08/00 OW of Ruth 01/20/53 Se% M fading Paiirai &kW. Addition.1 Informant err 14w and I ern: (Eel kt ketl I 09/20/13 00:00 Dale Cmered 09/21/13 that ad Time Reptwied 09/21/13 15:05ET Pli)malet Naar NM Ph) , se earl ID MERRELL Phone:800-631-5250 kg , Ordered Ca+PTH Intact TROTS RESULT FLAG UNITS REFERENCE INTERVAL LAN CaaPTH Intact Calcium, Serum 9.6 PTH, Intact 43 Intact PTH Interpretation mg/dL 8.6 - 10.2 01 pg/mL 15 - 65 01 01 Intact PTH Calcium (Pc/mL) (mg/dL) Normal 15 - 65 8.6 - 10.2 Primary Hyperparathyroidism >65 >10.2 Secondary Hyperparathyroidism >65 <10.2 Non-Parathyroid Hypercalcemia <65 >10.2 Hypoparathyroidism <15 < 8.6 Non-Parathyroid Hypocalcemia 15 - 65 < 8.6 01 RN LabCorp Raritan Dir: Araceli B Reyes, ND 69 First Avenue, Raritan, NJ 08869-1800 For inquiries, the physician may contact Branch. 800-631-5250 Labs 800-631-5250 EPSTEIN, JEFFREY 263-480-2784-0 Sal#5035 09/21/13 15:06 ET FINAL REPORT This document contains private and confidential health information protected by sure and federal law. If you have received this document in woe. please call 800-631-5250 Page 1 of 1 02004-13 Laboratory Corporation of America Holdings All Rights Reserved DOCI Vet 1.49 EFTA00304975 Corp Lab Wm,. '. 263-680-3 3 4 6-0 Nicol If) Control %anther CMH31143092 Acnioni Monier' 31143092 Acc. Plxine Number 212-535-1012 Rouic 70 rancid LW Namur EPSTEIN \wow Adam. Woodson Merrell 44 E 67th St New York NY 10065 Pawns lini Nanw JEFFREY Nike! /flak Name local Volume Aar omen) 60/08/00 asic of Dinh Cr. I ...imp 01/20/53 M No Palen* Adtliv... Allis, “aul Int onmenon Inare and Time Colln-red 09/20/13 14:00 I flak iaend 09/21/13 lute and MK Regional 09/23/13 09:05ET litywurn Name Nil My...ID MERRELL LabCorp Raritan 69 First Avenue Raritan NJ 08869-1800 Phone' 800-762-4344 "leg. (ktleral IC F -1 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB I0E-1 Insulin-Like Growth Factor I 127 ng/mL 51 - 194 01 01 SN LabCorp Burlington Dir: William F Hancock, MD 1447 York Court, Burlington, NC 27215-3361 For inquiries, the physician may contact Branch: 800-631-5250 Lab: 800-762-4344 EPSTEIN, JEFFREY 263-480-3346-0 &Noun 09/23/13 09:05 ET FINAL REPORT This document contains private and confidential health information protected by stale and federal law If you have received this document in error. please call 800 —631-5250 Page 1 of 1 O2004-13 Laboratory Corporation of America 0 Holdings All Ries Reserved DOM Vet 1.49 EFTA00304976